SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
MEDIROM Healthcare Technologies Inc. (MRM) trades at a trailing P/E of 0.0. Trailing earnings yield is 8,511.25%. Graham Number is $30.04.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.0); earnings yield beats bond yields (8,511.25%).
- Trailing Earnings Yield 8,511.25% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 62/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MRM
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio2.78
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$91.91
Book Value / Share$0.44
Revenue / Share$613.23
FCF / Share$-138.52
Yields & Fair Value
Earnings Yield8,511.25%
Dividend Yield0.00%
Graham Number$30.04
SharesGrow IV$8.55 (+578.6%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2018 |
118.0 |
0.00 |
-66.59 |
2.28 |
- |
| 2019 |
404.3 |
-5.44 |
11.68 |
1.79 |
- |
| 2020 |
-11.1 |
0.00 |
12.18 |
1.79 |
- |
| 2021 |
-3.4 |
-0.07 |
-16.31 |
0.63 |
- |
| 2022 |
21.7 |
-0.19 |
-54.48 |
0.47 |
- |
| 2023 |
36.2 |
-1.60 |
19.75 |
0.61 |
- |
| 2024 |
5.6 |
0.24 |
0.89 |
0.10 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$14.04 |
$3.43B |
$66.31M |
1.9% |
| 2019 |
$4.06 |
$3.91B |
$17.34M |
0.4% |
| 2020 |
$-133.97 |
$3.34B |
$-539.17M |
-16.1% |
| 2021 |
$-203.13 |
$5.41B |
$-990.73M |
-18.3% |
| 2022 |
$27.23 |
$6.95B |
$148.97M |
2.1% |
| 2023 |
$22.27 |
$6.83B |
$115.05M |
1.7% |
| 2024 |
$0.17 |
$8.3B |
$148.76M |
1.8% |
